Well-funded Danish startup 21st.Bio has taken a lease on a 12,000-square-foot office in Davis, which will be the first U.S. location for the life-sciences company.
The company licenses a library of microbial production strains and molecular tools from Novozymes, the world leader in industrial enzymes and microorganisms, which 21st.Bio helps other companies use to make their own products.
For the full story, go to Sacramento Inno.
© 2022 American City Business Journals. All rights reserved.